Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans
Authors
Keywords
Immune response, T cells, Vaccines, Antibody response, Antibodies, Cytotoxic T cells, HIV vaccines, Vaccination and immunization
Journal
PLoS One
Volume 15, Issue 1, Pages e0226803
Publisher
Public Library of Science (PLoS)
Online
2020-01-31
DOI
10.1371/journal.pone.0226803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
- (2018) Nicole L. Yates et al. JOURNAL OF VIROLOGY
- Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
- (2018) Linda-Gail Bekker et al. Lancet HIV
- Systems serology for evaluation of HIV vaccine trials
- (2017) Margaret E. Ackerman et al. IMMUNOLOGICAL REVIEWS
- Preventing acquisition of HIV is the only path to an AIDS-free generation
- (2017) Lawrence Corey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of UNAIDS targets and HIV vaccination across 127 countries
- (2017) Jan Medlock et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Probability-scale residuals for continuous, discrete, and censored data
- (2016) Bryan E. Shepherd et al. CANADIAN JOURNAL OF STATISTICS-REVUE CANADIENNE DE STATISTIQUE
- Power/sample size calculations for assessing correlates of risk in clinical efficacy trials
- (2016) Peter B. Gilbert et al. STATISTICS IN MEDICINE
- Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
- (2015) Amy W. Chung et al. CELL
- Increasing Complexity of Vaccine Development
- (2015) Stanley A. Plotkin JOURNAL OF INFECTIOUS DISEASES
- COMPASS identifies T-cell subsets correlated with clinical outcomes
- (2015) Lin Lin et al. NATURE BIOTECHNOLOGY
- HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition
- (2015) Heather A. Prentice et al. Science Translational Medicine
- Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials
- (2015) Xia Jin et al. VACCINE
- HVTN 097: Evaluation of the RV144 Vaccine Regimen in HIV Uninfected South African Adults
- (2014) Glenda E. Gray et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- OMIP-025: Evaluation of human T- and NK-cell responses including memory and follicular helper phenotype by intracellular cytokine staining
- (2014) Gemma Moncunill et al. CYTOMETRY PART A
- FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
- (2014) Shuying S. Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial
- (2014) A. J. Gartland et al. JOURNAL OF VIROLOGY
- Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
- (2014) Susan Zolla-Pazner et al. PLoS One
- Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
- (2014) Kathryn L. Hopkins et al. PLoS One
- Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
- (2014) N. L. Yates et al. Science Translational Medicine
- Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
- (2013) A. deCamp et al. JOURNAL OF VIROLOGY
- Molecular Evolution of the HIV-1 Thai Epidemic between the Time of RV144 Immunogen Selection to the Execution of the Vaccine Efficacy Trial
- (2013) G. H. Kijak et al. JOURNAL OF VIROLOGY
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
- (2013) G. D. Tomaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A new residual for ordinal outcomes
- (2012) C. Li et al. BIOMETRIKA
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
- (2011) Glenda E Gray et al. LANCET INFECTIOUS DISEASES
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
- (2008) G. D. Tomaras et al. JOURNAL OF VIROLOGY
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
- (2008) M Juliana McElrath et al. LANCET
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started